Skip to main content

Exagen Inc.

XGN
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001274737

In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.

Holders of 5% or more of XGN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Exagen Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of XGN
HolderLatest formStakeChangeFirst filedLatest filingFiling
Chernett Jorey13G/A9.90%2.41M shares+4.50 ppfrom 5.40%Feb 4, 20262 filingsMay 20, 2026SEC
NMSIC Co-Investment Fund, L.P.13G/A6.04%1.37M shares−3.79 ppfrom 9.83%Feb 11, 20217 filingsFeb 11, 2026SEC
Parian Ultreia LP13G5.30%1.29M sharesNewMay 27, 20261 filingMay 27, 2026SEC
Cowen Financial Products LLC13G/A5.00%891.4K shares–Dec 17, 20216 filingsMay 12, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

44 Schedule 13D and 13G filings on Exagen Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on XGN
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 27, 202612:33 PM ETParian Ultreia LP13G5.30%1.29M sharesNewMay 22, 2026SEC
May 20, 20265:47 PM ETChernett Jorey13G/A9.90%2.41M shares+4.50 ppfrom 5.40%Mar 31, 2026SEC
Feb 17, 20268:33 AM ETRTW Investments, LPand 1 other13G/A4.90%1.15M shares−2.80 ppfrom 7.70%Below 5%Dec 31, 2025SEC
Feb 11, 20264:15 PM ETNMSIC Co-Investment Fund, L.P.and 1 other13G/A6.04%1.37M shares−3.79 ppfrom 9.83%Dec 31, 2025SEC
Feb 4, 20262:31 PM ETChernett Jorey13G5.40%1.23M sharesNewJan 30, 2026SEC
Aug 14, 20251:51 PM ETLytton Laurence W13G/A1.00%216.8K shares–Below 5%Jun 30, 2025SEC
Aug 14, 20258:07 AM ETRTW Investments, LPand 1 other13G/A7.70%1.70M shares–Jun 30, 2025SEC
May 12, 20255:37 PM ETCowen Financial Products LLC13G/A5.00%891.4K shares–Mar 31, 2025SEC
Apr 17, 20254:15 PM ETNMSIC Co-Investment Fund, L.P.and 1 other13G/A9.83%1.76M shares−2.13 ppfrom 11.96%Mar 25, 2025SEC
Jan 29, 20257:00 PM ETNMSIC Co-Investment Fund, L.P.and 1 other13G/A11.96%2.11M shares–Dec 31, 2024SEC
Feb 14, 2024Lytton Laurence W13G/AOld format–––SEC
Feb 14, 2024RTW Investments, LP13G/AOld format–––SEC
Feb 13, 2024Tullis Dickerson Capital Focus III, L.P.13G/AOld format–––SEC
Feb 13, 2024Stonepine Capital Management, LLC13G/AOld format–––SEC
Feb 9, 2024Wasatch Advisors Inc13G/AOld format–––SEC
Feb 2, 2024Cowen Financial Products LLC13G/AOld format–––SEC
Jan 22, 2024NMSIC Co-Investment Fund, L.P.13G/AOld format–––SEC
Feb 14, 2023RTW Investments, LP13G/AOld format–––SEC
Feb 13, 2023Lytton Laurence W13G/AOld format–––SEC
Feb 13, 2023Stonepine Capital Management, LLC13G/AOld format–––SEC
Feb 9, 2023Wasatch Advisors Inc13G/AOld format–––SEC
Feb 7, 2023Tullis Dickerson Capital Focus III, L.P.13G/AOld format–––SEC
Feb 6, 202312:23 PM ETBank of Montreal13G/AOld format–––SEC
Feb 2, 2023NMSIC Co-Investment Fund, L.P.13G/AOld format–––SEC
Jan 23, 2023Cowen Financial Products LLC13G/AOld format–––SEC
Nov 23, 2022Lytton Laurence W13GOld format–New–SEC
Feb 15, 20229:48 AM ETBank of Montreal13GOld format–New–SEC
Feb 14, 2022Tullis Dickerson Capital Focus III, L.P.13G/AOld format–––SEC
Feb 14, 2022Stonepine Capital Management, LLC13G/AOld format–––SEC
Feb 14, 2022RTW Investments, LP13G/AOld format–––SEC
Feb 11, 2022Wasatch Advisors Inc13G/AOld format–––SEC
Feb 10, 2022NMSIC Co-Investment Fund, L.P.13G/AOld format–––SEC
Feb 8, 2022Hunt Holdings Limited Partnership13G/AOld format–––SEC
Jan 20, 2022Cowen Financial Products LLC13G/AOld format–––SEC
Jan 19, 2022Cowen Financial Products LLC13G/AOld format–––SEC
Dec 27, 2021Stonepine Capital Management, LLC13GOld format–New–SEC
Dec 17, 2021Cowen Financial Products LLC13GOld format–New–SEC
Apr 9, 2021Wasatch Advisors Inc13G/AOld format–––SEC
Feb 24, 2021H.I.G. Bio-Exagen, L.P.13DOld format–New–SEC
Feb 16, 2021Tullis Dickerson Capital Focus III, L.P.13G/AOld format–––SEC
Feb 16, 2021Hunt Holdings Limited Partnership13G/AOld format–––SEC
Feb 12, 2021RTW Investments, LP13G/AOld format–––SEC
Feb 11, 2021NMSIC Co-Investment Fund, L.P.13G/AOld format–––SEC
Feb 11, 2021Wasatch Advisors Inc13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Exagen Inc. shares.

No Form 144 notices for Exagen Inc. are on file.